1. Home
  2. VERA vs DEI Comparison

VERA vs DEI Comparison

Compare VERA & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • DEI
  • Stock Information
  • Founded
  • VERA 2016
  • DEI 1971
  • Country
  • VERA United States
  • DEI United States
  • Employees
  • VERA N/A
  • DEI N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • DEI Real Estate Investment Trusts
  • Sector
  • VERA Health Care
  • DEI Real Estate
  • Exchange
  • VERA Nasdaq
  • DEI Nasdaq
  • Market Cap
  • VERA 2.8B
  • DEI 3.2B
  • IPO Year
  • VERA 2021
  • DEI 2006
  • Fundamental
  • Price
  • VERA $43.91
  • DEI $20.32
  • Analyst Decision
  • VERA Strong Buy
  • DEI Hold
  • Analyst Count
  • VERA 9
  • DEI 7
  • Target Price
  • VERA $59.22
  • DEI $17.43
  • AVG Volume (30 Days)
  • VERA 434.6K
  • DEI 949.2K
  • Earning Date
  • VERA 11-07-2024
  • DEI 02-04-2025
  • Dividend Yield
  • VERA N/A
  • DEI 3.76%
  • EPS Growth
  • VERA N/A
  • DEI N/A
  • EPS
  • VERA N/A
  • DEI N/A
  • Revenue
  • VERA N/A
  • DEI $965,443,000.00
  • Revenue This Year
  • VERA N/A
  • DEI N/A
  • Revenue Next Year
  • VERA N/A
  • DEI N/A
  • P/E Ratio
  • VERA N/A
  • DEI N/A
  • Revenue Growth
  • VERA N/A
  • DEI N/A
  • 52 Week Low
  • VERA $14.20
  • DEI $12.36
  • 52 Week High
  • VERA $51.61
  • DEI $20.50
  • Technical
  • Relative Strength Index (RSI)
  • VERA 38.70
  • DEI 67.16
  • Support Level
  • VERA $43.13
  • DEI $19.34
  • Resistance Level
  • VERA $49.77
  • DEI $20.27
  • Average True Range (ATR)
  • VERA 1.97
  • DEI 0.39
  • MACD
  • VERA -0.74
  • DEI 0.06
  • Stochastic Oscillator
  • VERA 10.79
  • DEI 88.31

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is a real estate investment trust that acquires, develops, and manages office and multifamily properties in Los Angeles, California and Honolulu, Hawaii in the U.S. The company focuses on owning assets in communities with large supply constraints, such as the affluent neighborhoods of Los Angeles. The vast majority of Douglas Emmett's real estate portfolio is comprised of office buildings in Los Angeles. Most of these assets are located in the areas of Sherman Oaks, Woodland Hills, and Beverly Hills in terms of total square feet. Douglas Emmett derives nearly all of its income in the form of rental revenue from tenants. The vast majority of this also comes from its Los Angeles office buildings. The company's major tenants are legal, financial, and entertainment firms.

Share on Social Networks: